Skip to content
← Lobby Directory
UE
Other

Ultragenyx Europe Gmbh

Basel, SWITZERLANDLLC GmbhReg: 584987097561-93Since 09/04/2025

Budget

€100 — €0

EP Access

0

accredited persons

Staff

5

1.45 FTE

EU Grants

None

Mission & Goals

The Company's remit is to manufacture, trade, and distribute Ultragenyx products and services. Ultragenyx was founded to advance innovative medicines for rare and ultrarare diseases that have never been treated before. We are delivering transformative therapies across multiple indications, and we have one of the most robust and diverse clinical pipelines in rare disease. Our focus is on doing the right things for patients both during development and commercialization to deliver on the promise of these therapies in a way that's meaningful for rare disease communities.

EU Legislative Interests

Rare Diseases, Life Science and competitiveness

Communication Activities

media communications and events

Interests Represented

Promotes their own interests or the collective interests of their members

Member Of

EUCOPE European Confederation Pharmaceutical Entrepreneurs EURORDIS Rare Diseases Europe Association Regenerative Medicine US Chamber of Commerce

Commissioner Meetings

No recorded meetings with EU commissioners.